VioOne HIV Profile Supplemental Assay

Completed · Not applicable

Conditions studied: HIV Infections

In brief

Assessment of the sensitivity, specificity and reproducibility of the VioOne HIV Profile Supplemental Assay

Key facts

Study ID

NCT03727932

Run by

Avioq, Inc.

People needed

757

Starts

2018-01-03

Expected to finish

2018-04-11

Last updated by the study team

2018-11-02

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Specificity = 280 Serum Samples and 300 Plasma Samples
• An additional 20 Serum pediatric samples
• From low risk population (e.g. blood donors)
• Sensitivity = 757 Total Samples
• 400 HIV positive,
• 200 HIV-2 positive
• 50 AIDS positive
• 40 Pediatric
• 15 HIV-O positive
• 10 HIV-1/HIV-2 co-infected positive
• 27 samples from pregnant females with HIV

Where it is running

• Avioq Inc — Research Triangle Park, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.